The design, synthesis, and biological evaluation of PIM kinase inhibitors. 2012

Amy Lew Tsuhako, and David S Brown, and Elena S Koltun, and Naing Aay, and Arlyn Arcalas, and Vicky Chan, and Hongwang Du, and Stefan Engst, and Maurizio Franzini, and Adam Galan, and Ping Huang, and Stuart Johnston, and Brian Kane, and Moon H Kim, and A Douglas Laird, and Rui Lin, and Lillian Mock, and Iris Ngan, and Michael Pack, and Gordon Stott, and Thomas J Stout, and Peiwen Yu, and Cristiana Zaharia, and Wentao Zhang, and Peiwen Zhou, and John M Nuss, and Patrick C Kearney, and Wei Xu
Exelixis, Department of Drug Discovery, South San Francisco, CA 94080, USA. alew@exelixis.com

A series of substituted benzofuropyrimidinones with pan-PIM activities and excellent selectivity against a panel of diverse kinases is described. Initial exploration identified aryl benzofuropyrimidinones that were potent, but had cell permeability limitation. Using X-ray crystal structures of the bound PIM-1 complexes with 3, 5m, and 6d, we were able to guide the SAR and identify the alkyl benzofuropyrimidinone (6l) with good PIM potencies, permeability, and oral exposure.

UI MeSH Term Description Entries
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein
D051573 Proto-Oncogene Proteins c-pim-1 Serine-threonine protein kinases that relay signals from CYTOKINE RECEPTORS and are involved in control of CELL GROWTH PROCESSES; CELL DIFFERENTIATION; and APOPTOSIS. c-pim-1 Protein,pim-1 Proto-Oncogene Protein,Pim-1 Kinase,Proto-Oncogene Protein c-pim-1,Proto-Oncogene Protein pim-1,Kinase, Pim-1,Pim 1 Kinase,Proto Oncogene Protein c pim 1,Proto Oncogene Protein pim 1,Proto Oncogene Proteins c pim 1,c pim 1 Protein,c-pim-1, Proto-Oncogene Protein,c-pim-1, Proto-Oncogene Proteins,pim 1 Proto Oncogene Protein,pim-1, Proto-Oncogene Protein
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies

Related Publications

Amy Lew Tsuhako, and David S Brown, and Elena S Koltun, and Naing Aay, and Arlyn Arcalas, and Vicky Chan, and Hongwang Du, and Stefan Engst, and Maurizio Franzini, and Adam Galan, and Ping Huang, and Stuart Johnston, and Brian Kane, and Moon H Kim, and A Douglas Laird, and Rui Lin, and Lillian Mock, and Iris Ngan, and Michael Pack, and Gordon Stott, and Thomas J Stout, and Peiwen Yu, and Cristiana Zaharia, and Wentao Zhang, and Peiwen Zhou, and John M Nuss, and Patrick C Kearney, and Wei Xu
February 2021, Molecules (Basel, Switzerland),
Amy Lew Tsuhako, and David S Brown, and Elena S Koltun, and Naing Aay, and Arlyn Arcalas, and Vicky Chan, and Hongwang Du, and Stefan Engst, and Maurizio Franzini, and Adam Galan, and Ping Huang, and Stuart Johnston, and Brian Kane, and Moon H Kim, and A Douglas Laird, and Rui Lin, and Lillian Mock, and Iris Ngan, and Michael Pack, and Gordon Stott, and Thomas J Stout, and Peiwen Yu, and Cristiana Zaharia, and Wentao Zhang, and Peiwen Zhou, and John M Nuss, and Patrick C Kearney, and Wei Xu
May 2018, Bioorganic & medicinal chemistry,
Amy Lew Tsuhako, and David S Brown, and Elena S Koltun, and Naing Aay, and Arlyn Arcalas, and Vicky Chan, and Hongwang Du, and Stefan Engst, and Maurizio Franzini, and Adam Galan, and Ping Huang, and Stuart Johnston, and Brian Kane, and Moon H Kim, and A Douglas Laird, and Rui Lin, and Lillian Mock, and Iris Ngan, and Michael Pack, and Gordon Stott, and Thomas J Stout, and Peiwen Yu, and Cristiana Zaharia, and Wentao Zhang, and Peiwen Zhou, and John M Nuss, and Patrick C Kearney, and Wei Xu
August 2012, Bioorganic & medicinal chemistry letters,
Amy Lew Tsuhako, and David S Brown, and Elena S Koltun, and Naing Aay, and Arlyn Arcalas, and Vicky Chan, and Hongwang Du, and Stefan Engst, and Maurizio Franzini, and Adam Galan, and Ping Huang, and Stuart Johnston, and Brian Kane, and Moon H Kim, and A Douglas Laird, and Rui Lin, and Lillian Mock, and Iris Ngan, and Michael Pack, and Gordon Stott, and Thomas J Stout, and Peiwen Yu, and Cristiana Zaharia, and Wentao Zhang, and Peiwen Zhou, and John M Nuss, and Patrick C Kearney, and Wei Xu
December 2018, Bioorganic & medicinal chemistry letters,
Amy Lew Tsuhako, and David S Brown, and Elena S Koltun, and Naing Aay, and Arlyn Arcalas, and Vicky Chan, and Hongwang Du, and Stefan Engst, and Maurizio Franzini, and Adam Galan, and Ping Huang, and Stuart Johnston, and Brian Kane, and Moon H Kim, and A Douglas Laird, and Rui Lin, and Lillian Mock, and Iris Ngan, and Michael Pack, and Gordon Stott, and Thomas J Stout, and Peiwen Yu, and Cristiana Zaharia, and Wentao Zhang, and Peiwen Zhou, and John M Nuss, and Patrick C Kearney, and Wei Xu
October 2011, Journal of medicinal chemistry,
Amy Lew Tsuhako, and David S Brown, and Elena S Koltun, and Naing Aay, and Arlyn Arcalas, and Vicky Chan, and Hongwang Du, and Stefan Engst, and Maurizio Franzini, and Adam Galan, and Ping Huang, and Stuart Johnston, and Brian Kane, and Moon H Kim, and A Douglas Laird, and Rui Lin, and Lillian Mock, and Iris Ngan, and Michael Pack, and Gordon Stott, and Thomas J Stout, and Peiwen Yu, and Cristiana Zaharia, and Wentao Zhang, and Peiwen Zhou, and John M Nuss, and Patrick C Kearney, and Wei Xu
October 2009, Journal of medicinal chemistry,
Amy Lew Tsuhako, and David S Brown, and Elena S Koltun, and Naing Aay, and Arlyn Arcalas, and Vicky Chan, and Hongwang Du, and Stefan Engst, and Maurizio Franzini, and Adam Galan, and Ping Huang, and Stuart Johnston, and Brian Kane, and Moon H Kim, and A Douglas Laird, and Rui Lin, and Lillian Mock, and Iris Ngan, and Michael Pack, and Gordon Stott, and Thomas J Stout, and Peiwen Yu, and Cristiana Zaharia, and Wentao Zhang, and Peiwen Zhou, and John M Nuss, and Patrick C Kearney, and Wei Xu
April 2016, Bioorganic & medicinal chemistry,
Amy Lew Tsuhako, and David S Brown, and Elena S Koltun, and Naing Aay, and Arlyn Arcalas, and Vicky Chan, and Hongwang Du, and Stefan Engst, and Maurizio Franzini, and Adam Galan, and Ping Huang, and Stuart Johnston, and Brian Kane, and Moon H Kim, and A Douglas Laird, and Rui Lin, and Lillian Mock, and Iris Ngan, and Michael Pack, and Gordon Stott, and Thomas J Stout, and Peiwen Yu, and Cristiana Zaharia, and Wentao Zhang, and Peiwen Zhou, and John M Nuss, and Patrick C Kearney, and Wei Xu
December 2011, ACS medicinal chemistry letters,
Amy Lew Tsuhako, and David S Brown, and Elena S Koltun, and Naing Aay, and Arlyn Arcalas, and Vicky Chan, and Hongwang Du, and Stefan Engst, and Maurizio Franzini, and Adam Galan, and Ping Huang, and Stuart Johnston, and Brian Kane, and Moon H Kim, and A Douglas Laird, and Rui Lin, and Lillian Mock, and Iris Ngan, and Michael Pack, and Gordon Stott, and Thomas J Stout, and Peiwen Yu, and Cristiana Zaharia, and Wentao Zhang, and Peiwen Zhou, and John M Nuss, and Patrick C Kearney, and Wei Xu
December 2021, Bioorganic & medicinal chemistry letters,
Amy Lew Tsuhako, and David S Brown, and Elena S Koltun, and Naing Aay, and Arlyn Arcalas, and Vicky Chan, and Hongwang Du, and Stefan Engst, and Maurizio Franzini, and Adam Galan, and Ping Huang, and Stuart Johnston, and Brian Kane, and Moon H Kim, and A Douglas Laird, and Rui Lin, and Lillian Mock, and Iris Ngan, and Michael Pack, and Gordon Stott, and Thomas J Stout, and Peiwen Yu, and Cristiana Zaharia, and Wentao Zhang, and Peiwen Zhou, and John M Nuss, and Patrick C Kearney, and Wei Xu
October 2012, European journal of medicinal chemistry,
Copied contents to your clipboard!